8-K 1 immucor_8k-111010.htm CURRENT REPORT immucor_8k-111010.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
__________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
November 10, 2010     

IMMUCOR, INC.
(Exact name of registrant as specified in its charter)


Georgia
0-14820
22-2408354
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)

3130 Gateway Drive, Norcross, Georgia
30071
(Address of principal executive offices)
 (Zip Code)

Registrant's telephone number, including area code: (770) 441-2051

Not Applicable
(Former name or former address,
if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

Item 5.07.                      Submission of Matters to a Vote of Security Holders.
 
On November 10, 2010, Immucor, Inc. (the “Company”) held its annual meeting of the shareholders at the Company’s headquarters.
 
Eight directors were elected to the Board of Directors for one year terms expiring at the Company’s 2011 annual meeting of shareholders.  The shareholders also ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending May 31, 2011.  The final voting results on these matters were as follows:
 
1. Election of Directors
 
Nominee for Director
Affirmative Votes
Votes Withheld
Broker Non-Votes
James F. Clouser
56,739,067
1,300,192
5,212,031
Dr. Gioacchino De Chirico
57,062,859
976,400
5,212,031
Dr. Paul V. Holland
56,723,029
1,316,230
5,212,031
Ronny B. Lancaster
56,735,821
1,303,438
5,212,031
Dr. Paul Mintz
54,423,658
3,615,601
5,212,031
G. Mason Morfit
56,914,292
1,124,967
5,212,031
Chris E. Perkins
57,097,425
941,834
5,212,031
Joseph E. Rosen
55,416,789
2,622,470
5,212,031

2.  Ratification of the Appointment of Grant Thornton LLP as the Company’s Independent Registered Public Accounting Firm for the Company’s fiscal year ending May 31, 2011:
 
Votes For
Votes Against
Votes Abstained
63,125,089
93,497
32,704

 
 
 

SIGNATURES
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
  IMMUCOR, INC.  
       
       
       
Date: November 16, 2010
By:
/s/ Philip H. Moïse  
   
Philip H. Moïse
  
    Executive Vice President and General Counsel